Céline Vaessen
Chief Investment Officer bij SFPI-FPIM (Private Equity)
Oorsprong van het eerstegraads netwerk van Céline Vaessen
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
SFPI-FPIM SA/NV
 SFPI-FPIM SA/NV Financial ConglomeratesFinance Société Fédérale de Participations et d’Investissement SA operates as a state-owned investment company. It engages in investments in public and private companies in economic and cross-cutting sectors such as sustainable development, innovation, airport and aviation, real estate, and ageing of the population. The company was founded on November 1, 2006 and is headquartered in Brussels, Belgium.
25
| Sovereign Wealth Fund | Financial Conglomerates | 25 |
Univercells SA
 Univercells SA BiotechnologyHealth Technology Univercells SA designs single-use cost-efficient bioprocess solutions to open the next chapter in bio manufacturing. The company was founded by Jose Castillo, Guillaume De Viron and Hugues Bultot in 2013 and is headquartered in Gosselies, Belgium.
10
| Holding Company | Biotechnology | 10 |
Maison de la Radio Flagey SA
 Maison de la Radio Flagey SA Miscellaneous Commercial ServicesCommercial Services Maison de la Radio Flagey SA manages spaces intended for cultural activities. The company was founded by Baron Berghmans in 1998 and is headquartered in Ixelles, Belgium.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
SFPI-FPIM (Private Equity)
 SFPI-FPIM (Private Equity) Investment ManagersFinance SFPI FPIM /PRIVATE EQUITY/ (SFPI FPIM) is the private equity division of SFPI-FPIM SA/NV, which is ultimately-owned by the state of Belgium. The firm was founded in 1994, and is headquartered in Brussels, Belgium.
7
| Operating Division | Investment Managers | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Céline Vaessen via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Metalmark Capital LLC
 Metalmark Capital LLC Investment ManagersFinance Metalmark Capital LLC (Metalmark Capital) is a private equity firm founded by John J. Moon in 1986. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
| EUROCINE VACCINES AB | Pharmaceuticals: Major | Chairman | |
Compagnie Benelux Participations SA
 Compagnie Benelux Participations SA Investment ManagersFinance Compagnie Benelux Participations SA (Cobepa) is an indepndant private equity firm, a subsidiary of Cobehold SA founded in 1957. The firm is headquartered in Brussels, Belgium with additional offices in New York, New York and Munich, Germany. | Investment Managers | Director of Finance/CFO | |
| CEGEDIM | Packaged Software | Sales & Marketing | |
| FLUXYS BELGIUM SA | Gas Distributors | Corporate Officer/Principal Director/Board Member | |
| TEXAF S.A. | Real Estate Development | Director of Finance/CFO | |
| GREENHILL & CO., INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
| BPOST SA/NV | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| INSEAD | College/University | Undergraduate Degree | |
| THERADIAG | Medical Specialties | Chairman | |
| International Institute for Management Development | College/University | Undergraduate Degree | |
| Université Libre de Bruxelles | College/University | Graduate Degree Corporate Officer/Principal Graduate Degree | |
| ESSEC Business School | College/University | Masters Business Admin | |
| ICHEC | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Sales & Marketing | |
| University of Lyon | College/University | Doctorate Degree | |
| Firma Beel | Director/Board Member | ||
Société Wallonne du Crédit Social
 Société Wallonne du Crédit Social Finance/Rental/LeasingFinance Société Wallonne du Crédit Social provides loan and mortgage services. The company was founded on December 22, 2000 and is headquartered in Charleroi, Belgium. | Finance/Rental/Leasing | Director/Board Member | |
InterXion Belgium BV
 InterXion Belgium BV Information Technology ServicesTechnology Services Interxion Belgium NV provides computer facilities management services. The company was founded in 2000 and is headquartered in Zaventem, Belgium. | Information Technology Services | Director of Finance/CFO | |
Certi-Fed SA
 Certi-Fed SA Financial ConglomeratesFinance Certi-Fed SA is an investment holding Belgian company founded in 2007. The private company is based in Brussels, Belgium. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
| Association Belge des Analystes Financiers | Corporate Officer/Principal | ||
Lorentz, Deschamps & Associés SAS
 Lorentz, Deschamps & Associés SAS Investment ManagersFinance Lorentz, Deschamps & Associés SAS is a private company based in Paris, France that provides financial advisory services. | Investment Managers | Corporate Officer/Principal | |
| Amis du Musée Royal de l'Afrique Centrale | Chairman | ||
Minervax ApS
 Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member | |
| AMOÉBA | Household/Personal Care | Director/Board Member | |
Capricorn ICT Arkiv NV
 Capricorn ICT Arkiv NV Investment ManagersFinance Capricorn ICT Arkiv NV invests in companies located in Western Europe. It targets companies operating in the fields of digital healthcare & data driven projects. It provides financing for seed stage, early stage and growth stage in equity and debt with an investment size between EUR 0.5 million and 5 million. It targets to acquire minority stakes but also takes majority stakes. | Investment Managers | Director/Board Member Director/Board Member | |
| CANSINO BIOLOGICS INC. | Biotechnology | Director/Board Member | |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree | |
| Solvay Business School of Economics & Management | College/University | Masters Business Admin Corporate Officer/Principal | |
Global Health Investment Fund
 Global Health Investment Fund Investment ManagersFinance Global Health Investment Fund seeks investment opportunities in global health technologies. The fund invests in new drugs & vaccines, emerging diagnostic tools, child-friendly formulations of existing products, expanding manufacturing capacity and other applications. It provides financing in the form of mezzanine for later-stage capital requirements. | Investment Managers | Private Equity Analyst Private Equity Investor | |
| IMBAKIN HOLDING SA | Financial Conglomerates | Chairman | |
| Jean Moulin University Law School | College/University | Graduate Degree | |
Virometix AG
 Virometix AG Pharmaceuticals: MajorHealth Technology Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray. | Pharmaceuticals: Major | Chairman | |
Meaunet SA
 Meaunet SA Real Estate DevelopmentFinance Meaunet SA is a Belgian company that provides real estate services. The private company is based in Ixelles, Belgium. The CEO of the company is Ingrid Bonnet. | Real Estate Development | Director/Board Member Director/Board Member | |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Innovation Fund (BE)
 Innovation Fund (BE) Investment ManagersFinance Innovation Fund is a venture capital firm founded in 2015. The firm headquartered located in Schaerbeek, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
Frontier Nutrition, Inc.
 Frontier Nutrition, Inc. Food: Specialty/CandyConsumer Non-Durables Frontier Nutrition, Inc. develops and manufactures fortified packaged food. Its recipes are localized for traditional diets, taste, and nutrition. The company was founded by Eddie Bearnot and Tanveer Ali on August 18, 2016 and is headquartered in DE. | Food: Specialty/Candy | Director/Board Member | |
| Alma Biotherapeutics | Chairman | ||
| Mrgn Advisors | Chief Executive Officer | ||
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Investment Managers | Founder Founder | |
LimmaTech Biologics AG
 LimmaTech Biologics AG Miscellaneous Commercial ServicesCommercial Services LimmaTech Biologics AG is a clinical stage biopharmaceutical company based in Schlieren, Switzerland. LimmaTech Biologics is dedicated to combating the antimicrobial resistance epidemic by developing vaccines using its proprietary self-adjuvanting and multi-antigen vaccine platform, alongside additional disease-specific vaccine approaches. The Swiss company has decades of expertise and an expanding pipeline, and is focused on generating protective solutions to deliver transformative value worldwide. The company was founded in 2015 by Philippe Dro, Michael Wacker, Paul Wolfarm, Michael Kowarik, Veronica Gambillara Fonck. Franz-Werner Haas has been the CEO of the company since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
| AN2 THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Quantoom Biosciences SA
 Quantoom Biosciences SA Pharmaceuticals: OtherHealth Technology Quantoom Biosciences SA is a Belgian company that is focused on revolutionizing mRNA production through the development of their platform, ntensify. The private company is based in Nivelles, Belgium. This platform includes DNA amplification and RNA manufacturing, with the ntensify systems being the core of their RNA production technology. The company is made up of a team of scientists, engineers, and clinicians who are dedicated to addressing the major challenges in DNA and RNA production for vaccines and therapeutics. | Pharmaceuticals: Other | Director/Board Member | |
Thaumas NV
 Thaumas NV Financial ConglomeratesFinance Thaumas NV is an investment holding Belgian company founded in 2018. The private company is based in Beveren, Belgium. | Financial Conglomerates | Director/Board Member Director/Board Member | |
ORIZIO BV
 ORIZIO BV Aerospace & DefenseElectronic Technology Orizio BV is a Belgian company that designs and manufactures aviation and aerospace equipment. The private company is based in Brussels, Belgium. The company was founded in 2020. | Aerospace & Defense | Director/Board Member Director/Board Member | |
Euroports Group BV
 Euroports Group BV Other TransportationTransportation Euroports Group BV is a Belgian port-infrastructure company that handles over 65 million tons of essential commodities annually. The private company is based in Kallo, Belgium and was founded in 2006. The company is focused on digital transformation to enhance its readiness for the future and develop innovative solutions to combat future challenges. Euroports offers end-to-end maritime supply-chain solutions by rail, road, and inland waterway. The company handles food-grade sugar at their sugar terminals and tons of fossil fuels, mainly coal and petcoke, for major international electric utilities at their reception and storage facilities. Frédéric Platini has been the CEO of the company since 2019. | Other Transportation | Director/Board Member |
Statistieken
Internationaal
| België | 23 |
| Frankrijk | 10 |
| Verenigde Staten | 7 |
| Zweden | 4 |
| Zwitserland | 4 |
Sectoraal
| Finance | 16 |
| Health Technology | 10 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 143 |
| Corporate Officer/Principal | 28 |
| Chairman | 19 |
| Private Equity Investor | 16 |
| Director of Finance/CFO | 15 |
Sterkste connecties
| Insiders | |
|---|---|
| François Fontaine | 34 |
| Pierre Armand Morgon | 29 |
| Koenraad van Loo | 22 |
| Timothy Morris | 21 |
| Glenn Rockman | 17 |
| Hugues Bultot | 13 |
| Andrin Oswald | 12 |
| Christophe Evers | 12 |
| Kabeer Aziz | 12 |
| Léon Cappaert | 10 |
| Matthieu de Posch | 7 |
| Douglas A. Neugold | 6 |
| Hubert Bonnet | 6 |
| Laurence Bovy | 5 |
| Olivier Henin | 5 |
- Beurs
- Insiders
- Céline Vaessen
- Bedrijfsconnecties
